Ignite Creation Date:
2024-05-05 @ 11:55 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00177996
Status:
COMPLETED
Last Update Posted:
2016-01-15
First Post:
2005-09-13
Brief Title:
Pharmacotherapy in Depression With Panic Spectrum
Sponsor:
University of Pittsburgh
Organization:
University of Pittsburgh
Study Overview
Official Title:
Pharmacotherapy in Depression With Panic Spectrum
Status:
COMPLETED
Status Verified Date:
2016-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This research study is being conducted to find out if certain individuals benefit from taking medication for their depression with a low dose of the antidepressant medication Zoloft
Detailed Description:
Researchers at the University of Pittsburgh Medical Center Health System are currently recruiting men and women ages 18 to 60 to examine the effectiveness of the FDA-approved medication sertraline Zoloft for major depression
Participants will be randomly assigned to one of two groups Each group will begin and continue taking Zoloft at different doses A physician will follow eligible participants weekly for approximately 12 weeks
Participants will be randomly assigned to one of two groups Each group will begin and continue taking Zoloft at different doses A physician will follow eligible participants weekly for approximately 12 weeks
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None